mortality/aging
• at 1 year, some mice die or are euthanized due to rectal prolapse or debility
|
digestive/alimentary system
• fewer goblet cells in the small and large intestines due to increased apoptosis
|
• in distal large intestine
|
• increased in distal large intestine
|
• increased crypt length in the cecum and distal large intestine with increased intestinal proliferation and apoptosis
|
• progressive increase in proximal and distal colon thickness and weight from 6 to 18 weeks
• however, colon length is not shortened
|
• in some mice
|
• in DSS-treated mice with early fecal occult blood
|
• in DSS-treated mice
|
immune system
• in DSS-treated mice with early fecal occult blood
|
• in DSS-treated mice
|
• 5-fold increase in leukocytes in the mesenteric lymph node leukocytes in untreated mice
|
• from distal colon explants
|
• from distal colon explants
|
• from distal colon explants
• from mesenteric lymph nodes stimulated with PMA and ionomycin
|
cellular
• fewer goblet cells in the small and large intestines due to increased apoptosis
|
• distended cells with membranous vacuolar material in the large intestine
• goblet cells possess dilated rough endoplasmic reticulum
|
• swollen mitochondria with disrupted cristae in the large intestine
|
• swollen mitochondria with disrupted cristae in the large intestine
|
• in distal large intestine
|
• increased in distal large intestine
|
• aberrant mucin assembly triggers an endoplasmic reticulum stress response and unfolded protein response activation
|
endocrine/exocrine glands
• increased crypt length in the cecum and distal large intestine with increased intestinal proliferation and apoptosis
|
hematopoietic system
• 5-fold increase in leukocytes in the mesenteric lymph node leukocytes in untreated mice
|
neoplasm
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
inflammatory bowel disease | DOID:0050589 |
OMIM:PS266600 |
J:194148 |